Bristol Myers Squibb CEO Chris Boerner sits down with CNBC's Angelica Peebles at the American Society of Clinical Oncology's ...
Summit said Harmoni-6 is the first Phase 3 study to show a "statistically significant" survival advantage over a PD-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results